Laurus Labs recorded steep decline in revenue growth & net profit in FY15

Premium

Vishakhapatnam-based drug ingredients maker Laurus Labs, which has true-blue private equity firm Warburg Pincus on board as an investor and is now planning an initial public offer, saw its revenue growth slowing phenomenally in 2014-15 vis-à-vis the previous two financial years. The company also recorded a steep decline of close ......